Podcasts about Prevalence

Du wachst auf, bist hellwach – und kannst dich nicht rühren. Etwas drückt auf deine Brust, im Zimmer steht eine dunkle Gestalt, du willst schreien und bringst keinen Ton heraus. Was passiert da gerade? In dieser Folge sprechen Franca und Christian über die Schlafparalyse – eine Grenzerfahrungen des Schlafs, die mehr Menschen erleben als man glaubt. Sie entsteht, wenn das Bewusstsein schon wach ist, während der Körper noch in der Muskellähmung des Traumschlafs feststeckt. Für die allermeisten Menschen ist sie völlig harmlos – und je besser man weiß, was da passiert, desto weniger Macht hat sie über einen. Francas neues Buch: Die innere Oma — ab 4. September 2026, jetzt kurze Zeit mit handschriftlicher Signatur vorbestellbar: https://shop.autorenwelt.de/products/die-innere-oma-von-franca-cerutti Alle Tourdaten und Tickets für Dezember: https://www.190a.de/psychologie-to-go/ Unterstütze uns auf Steady: https://steady.page/de/psychologie-to-go/about Hinterlasse eine Frage oder einen Kommentar auf unserem Anrufbeantworter: https://www.speakpipe.com/Psychologietogo Quellen: Sharpless, B. A. (2016): A clinician's guide to recurrent isolated sleep paralysis. Neuropsychiatric Disease and Treatment. DOI: https://doi.org/10.2147/NDT.S100307 Hefnawy, M. T. et al. (2024): Prevalence and Clinical Characteristics of Sleeping Paralysis. Cureus (Open Access). DOI: https://doi.org/10.7759/cureus.53212 Jalal, B. (2018): The neuropharmacology of sleep paralysis hallucinations. Psychopharmacology. DOI: https://doi.org/10.1007/s00213-018-5042-1 Denis, D., French, C. C., Gregory, A. M. (2018): A systematic review of variables associated with sleep paralysis. Sleep Medicine Reviews. DOI: https://doi.org/10.1016/j.smrv.2017.05.005 Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte: https://linktr.ee/psychologietogo Du möchtest Werbung in diesem Podcast schalten? Dann erfahre hier mehr über die Werbemöglichkeiten bei Seven.One Audio: https://www.seven.one/portfolio/sevenone-audio

In episode 381 of The Physical Performance Show, host Brad Beer — sports and exercise physiotherapist — sits down with Pogo physiotherapist Tim Studley for the first instalment of a two-part mini-series on shin pain and tibial bone stress injuries, following on from their earlier three-part bone stress injury series. This episode is essential listening for runners, coaches, and clinicians alike, unpacking how to tell the difference between medial tibial stress syndrome (MTSS/shin splints) and a true tibial bone stress injury — two conditions that can feel identical but require completely different management. Brad and Tim walk through the physiology of bone loading, the palpation tests that separate a "safe to keep running" diagnosis from one requiring an MRI, and the loading tests used to stress-test the tibia safely in clinic. Show Sponsor: Pillar Performance continues to lead the way in sports nutrition through micro-nutrition innovation, now expanding into the Performance Health range. One of their newest releases, Collagen Repair, was developed with Gelita Laboratories (Germany) using a clinically trialled collagen peptide (Tendofort) to support tendon and ligament health in conditions like hamstring tendinopathy, Achilles tendonitis, shin splints, and patellofemoral pain. Head to pillarperformance.shop (or thefeed.com for North American listeners) and use code PHYSICALPERFORMANCE for 15% off your first purchase. Pogo Physio also offers online Telehealth Consultations for endurance athletes managing bone, tendon, or joint issues — book online at https://pogophysio.com.au. Listen in as we delve into the following: The prevalence of tibial bone stress injuries and why the shin is the most common bone stress site in runners Why bone stress injuries occur: workload errors, loading frequency vs. magnitude, and individualised risk factors The continuum from "happy bone" to stress reaction to frank stress fracture Why pain magnitude doesn't reliably predict injury severity The heterogeneity of bone innervation and why the periosteum is key to understanding pain Differentiating MTSS from tibial bone stress injury — and why the management is entirely different The 10cm palpation rule: a clinical prediction rule for when to suspect bone vs. soft tissue Why the anterior (front) shin is a higher-risk, non-union-prone injury site The loading-test ladder: double leg calf raise → single leg calf raise → single leg hop → side-to-side hop → forward hop The role of muscle-bone synergy: how calf strength and girth influence tibial bone stress risk Recovery timelines by injury grade, and why MRI matters for prognosis and athlete buy-in A real case study: a triathlete's navicular injury, deconditioning, and return to tibial bone stress injuries Quotes "You can go from hero to zero really quickly with bone."  "Higher levels of pain don't necessarily mean a worse injury."  "Muscle loads bone."  Timeline 00:00 – Introduction & sponsor: Pillar Performance 02:15 – Introduction to Tim and Brad's conversation 02:27 – Prevalence of tibial bone stress injuries 03:56 – Why bone stress injuries occur: workload and biomechanics 05:22 – Symptom patterns: bone stress injury vs. other shin pain 07:42 – Heterogeneity of bone innervation and pain variability 10:10 – Why pain severity doesn't predict injury severity 11:07 – MTSS vs. bone stress injury: two schools of thought 12:06 – Brad's clinical experience and personal injury history 13:59 – Cardinal signs and symptom progression in MTSS 15:23 – The three-legged stool: history, physical exam, imaging 16:19 – The 10cm palpation rule explained 19:43 – Applying the rule in practice 20:42 – Anterior shin pain: a higher-risk presentation 21:39 – Loading tests: from calf raises to forward hopping 24:07 – Individualising the loading-test progression 26:03 – Does the 10cm rule apply anteriorly? 26:55 – History as the biggest predictor of reinjury 27:53 – MRI, prognosis, and grading via the Fredericksons scale 29:15 – Reading hesitancy and movement quality in loading tests 31:10 – Why bone stress injuries aren't purely about vertical impact 33:03 – Calf girth and bone stress risk correlation 34:56 – Case study: a triathlete's navicular injury and recovery 35:58 – Episode close & sponsor mentions THE TEAM: Join The Physical Performance Show LEARNINGS membership through weekly podcasts here: https://www.patreon.com/TPPShow Our goal is to get you back to your Physical Best. Find out more about Telehealth Consultations and book online at pogophysio.com.au. Your Hosts:

It's estimated that 1 in 8 women have PMOS. Most of them have never even heard of it.   You probably know it by its old name: PCOS.   In one of the biggest updates to women's health in years, experts officially changed the name from Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) because the old name missed the bigger picture. This isn't just about ovaries. It's about your metabolism, your hormones, your blood sugar, your energy, and how your entire body functions.   If you've been battling stubborn weight, acne, irregular periods, facial hair, anxiety, food noise, infertility, fatigue, inflammation, or you constantly feel like your body isn't responding no matter how "healthy" you're trying to be, this episode is for you.   Joining Jamie once again is Nutritional Therapy Practitioner and "Your Blood Sugar Bestie" Ashley Lawrence, who was diagnosed with PMOS herself and has since reversed her symptoms and lost her diagnosis by getting to the root cause instead of chasing them one at a time.   Together, they break down what this name change actually means for you, why so many women have slipped through the cracks for years, and how all those random, frustrating symptoms you've been dealing with might actually be connected to the same root cause.   You'll learn: • PCOS → PMOS: why the name changed and what it really means • Insulin resistance in PMOS (even without weight gain) • Prevalence: 1 in 8 women, many undiagnosed • Blood sugar dysregulation and its impact on hormones, mood, digestion, inflammation, fertility, and energy • Why calorie restriction and high-intensity workouts can backfire • Ashley's simple blood sugar–balancing meal formula to reduce cravings and food noise • Key supports: therapeutic teas, minerals, movement, and lifestyle habits for hormone balance • How Ashley reversed her symptoms using Foundations of Health vs. heavy supplement protocols • Sustainable healing without extreme restriction     If you've ever wondered why your friend can skip meals, survive on iced coffee, work out six days a week, and lose weight while you feel exhausted doing everything "right," this conversation will help you understand why.   Your body isn't failing you. It's communicating with you. And when you learn its language and listen to its wisdom, everything changes. _______________________________________________________________________________ If this episode encouraged you, challenged your thinking, or gave you hope, please share it with someone you love. AND SUBSCRIBE! Leave a review. Write a comment on Spotify. Just come back for more! If we're going to change the world, we're going to need YOU. :-) _______________________________________________________________________________   A Few Related Episodes: S2E2: Healthy Eating Made Easier Using AI S1E85: Sugar Sugar S1E83: How to "Eat Real Food" S1E81: Wellness 101 S1E80: Digestive Hell S1E79: Optimal Digestion S1E74: Dehydration Nation S1E29: Quick Tips for Blood Sugar Regulation S2E28: Blood Sugar 101 S1E21: Stress ASHLEY'S OTHER EPISODES: S1E62: Quick Tips from "Your Blood Sugar Bestie" S1E61: PCOS Root Cause     Connect with Ashley on Instagram:  ⁠https://www.instagram.com/magicandwellness⁠   Connect with Jamie on Instagram:  ⁠https://www.instagram.com/jamiebelzfntp/⁠⁠⁠ ⁠https://www.instagram.com/stories/thebodywisdompodcast/⁠   Work with a Nutritional Therapy Practitioner (NTP): ⁠NTP in Private Practice⁠ ⁠NTP at NTA Health ⁠    Check out the Nutritional Therapy Association: ⁠⁠https://www.nutritionaltherapy.com/⁠⁠   Join a webinar to see if the Nutritional Therapy Practitioner Program is right for you!: ⁠https://www.nutritionaltherapy.com/webinars⁠   Follow the NTA on Instagram: ⁠⁠https://www.instagram.com/ntatraining/⁠⁠

Dr. Robyn Nadolny is a Biologist and the Chief of the Vector-Borne Disease Branch at the Defense Centers for Public Health at Aberdeen Proving Ground, MD (DCPH-A). The flagship program of the Vector-Borne Disease Branch is MilTICK, a free, rapid tick-testing program for military beneficiaries. The results provide a tool in the diagnostic toolbox for military beneficiaries, and Dr. Nadolny uses the passive surveillance data generated to better understand changing tick-borne disease dynamics and mitigate risks to US Service Members and their communities. She is also working on tick-borne disease surveillance projects worldwide to support military communities. Dr. Nadolny came to DCPH-A in 2016 after completing her PhD in Ecological Sciences from Old Dominion University (ODU) in Norfolk, VA. She also holds a M.S. in Biology from ODU, and a B.S. in Ecology, Evolution, and Behavioral Biology from Beloit College in Beloit, WI. Her research focuses on the prevention of tick-borne disease through understanding and breaking tick-host-pathogen-environment cycles. Dr. Nadolny has co-authored over 30 peer-reviewed publications and is interested in the intersection of ecology and public health.In this episode, we discuss the types of diseases that can be transmitted to military personnel (and anyone else) through ticks, how those diseases work, where and when the risk is greatest, and what you can do to protect yourself. To visit the MilTICK site, which you can use to understand the risk of tick-borne disease at your military installation and submit ticks for testing, go here:https://ph.health.mil/topics/entomology/kits/Pages/HumanTickTestKitProgram.aspxThere are also many civilian labs where you can submit a tick for testing at a low cost. For example:Pennsylvania Tick Research Lab: https://www.ticklab.org/Old Dominion University, Virginia: https://sites.wp.odu.edu/tick-team/what-we-do/tick-testing/sending-us-your-ticks/Ticknology: https://www.ticknology.org/order-testTimestamps:00:23 Introduction to Dr. Robyn Nadolny01:48 What are the Most Common Diseases Spread by Ticks?03:24 Lesser Known Tick-Spread Diseases07:19 Alpha Gal: It's Not Just Beef Off the Table 09:27 The Implications of Lyme Disease14:16 How Does the Body React After Multiple Tick Bites?16:06 Rates of These Diseases 18:21 What Terrain Do Ticks Prefer? 21:31 What Time of Year are Ticks the Worst?23:13 Tick Life Cycles  27:56 Soldiers Protecting Themselves from Ticks in the Field33:19 Dealing with a Tick Bite in the Field37:41 Prevalence of Diseases in Ticks42:34 Vaccines for Tick-Borne Diseases for Pets and People45:45 Treated Clothing and Repellents48:21 OutroSend us a message

In our first summer series episode, we review a topic that keeps coming back. Hormone therapy for menopause. It was a thing, then it stopped being a thing, now it's a thing again.   Become a supporter of our show today either on Patreon or through PayPal! Thank you! http://www.patreon.com/thebodyofevidence/ https://www.paypal.com/donate?hosted_button_id=9QZET78JZWCZE   Email us your questions at thebodyofevidence@gmail.com.   Editor:    Robyn Flynn Theme music: “Fall of the Ocean Queen“ by Joseph Hackl Rod of Asclepius designed by Kamil J. Przybos Chris' book, Does Coffee Cause Cancer?: https://ecwpress.com/products/does-coffee-cause-cancer   Obviously, Chris is not your doctor (probably). This podcast is not medical advice for you; it is what we call information. References:  Geographic variability of menopausal symptoms   1) Nappi RE et al. Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden. Menopause. 2021 May 24;28(8):875-882. doi: 10.1097/GME.0000000000001793.    2) Nappi RE, et al.  Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey. Maturitas. 2023 Jan;167:66-74. doi: 10.1016/j.maturitas.2022.09.006.    What's the normal duration of symptoms   3) Avis NE, et al. Study of Women's Health Across the Nation. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015 Apr;175(4):531-9. doi: 10.1001/jamainternmed.2014.8063.  The Women's Health Initiative (WHI) studies   Rossouw JE et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.    Anderson GL et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004 Apr 14;291(14):1701-12. doi: 10.1001/jama.291.14.1701.   Decline in HRT after WHI studies   Sprague BL, Trentham-Dietz A, Cronin KA. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol. 2012 Sep;120(3):595-603. doi: 10.1097/AOG.0b013e318265df42.   Danish Osteoporosis Prevention Study Schierbeck LL metal. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012 Oct 9;345:e6409. doi: 10.1136/bmj.e6409.   Kronos Early Estrogen Prevention Study (KEEPS) Harman SM, et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med. 2014 Aug 19;161(4):249-60. doi: 10.7326/M14-0353.   Kronos Early Estrogen Prevention Study (KEEPS) Hodis HN et al. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. N Engl J Med. 2016 Mar 31;374(13):1221-31. doi: 10.1056/NEJMoa1505241.    Stopping hormonal therapy   Berman RS et al. Risk factors associated with women's compliance with estrogen replacement therapy. J Womens Health. 1997 Apr;6(2):219-26. doi: 10.1089/jwh.1997.6.219.   Grady D, Sawaya GF. Discontinuation of postmenopausal hormone therapy. Am J Med. 2005 Dec 19;118 Suppl 12B:163-5. doi: 10.1016/j.amjmed.2005.09.051.   Tapering vs. abrupt stop or hormonal therapy   Haimov-Kochman R et al. Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study. Menopause. 2006 May-Jun;13(3):370-6. doi: 10.1097/01.gme.0000186663.36211.c0. PMID: 16735933.

Are you noticing that you are tired all the time and cannot seem to hit your paces in training? Those are not symptoms to ignore. Sometimes, these are signs of low ferritin levels that warrant bloodwork and a doctor visit. In this episode, we examine the research on low ferritin and running, including the causes, how to treat, and how to prevent low ferritin.Thank you to our sponsors:✨ Mizuno: Shop Mizuno's newest bouncy supertrainer: https://runtothefinish.com/neovista3/In this episode, you'll learn:✅ Why general population reference ranges for iron are not appropriate for endurance athletes✅ Why iron and ferritin levels matter so much for runners✅ Signs and symptoms of low ferritin levels in runners✅ Why runners are so prone to low ferritin levels✅ How long it takes for iron levels to increase✅ What impacts your iron intake and absorptionReferences

Wars get the headlines. A civil war can wreck a country's economy and dominate its news for a decade. But if you assume war is the most costly form of violence a society faces, you would be wrong.In this week's VoxDev Talk, James Fearon (Stanford) joins Tim Phillips to argue that the violence happening quietly inside homes and on ordinary streets does far more damage than war and terrorism combined.Drawing on his new book Worse Than War (PUP), written with Anke Hoeffler, Fearon estimates that interpersonal violence, meaning homicide, intimate partner violence and severe physical abuse of children, kills and injures more people than war, and costs society more too. Large-scale collective violence hits very few countries in any year. Almost every country carries rates of homicide and assault that exceed the global average for war.Fearon's argument is not that war does not matter. It is that the interpersonal violence is less dramatic and often hidden from view. There is evidence on what works to reduce it, but we aren't giving the problem the attention it needs.The book behind this episode:Hoeffler, Anke, and James D. Fearon. 2026. Worse than War: The Global Costs of Violence. Princeton: Princeton University Press.To cite this episode:Phillips, Tim, and James Fearon. 2026. "Interpersonal violence costs the world more than" VoxDev Talk (podcast). About James FearonJames Fearon is the Theodore and Frances Geballe Professor in the School of Humanities and Sciences and professor of political science at Stanford University, and a senior fellow at the Freeman Spogli Institute for International Studies. His research spans civil and interstate war, ethnic conflict, the international spread of democracy, the evaluation of foreign aid and institution building, and the costs of collective and interpersonal violence. He was elected to the National Academy of Sciences in 2012 and the American Academy of Arts and Sciences in 2002.The book is co-authored with Anke Hoeffler, professor of development research at the University of Konstanz and co-author of Breaking the Conflict Trap, whose work on the economics of civil war includes the influential conflict-trap research with Paul Collier.Research and concepts discussed in this episodeInterpersonal versus collective violence. The book distinguishes collective violence, perpetrated by organised groups such as states, rebel organisations, terrorists, or criminal gangs, from interpersonal violence, committed by individuals. Interpersonal violence is broken down into homicide, intimate partner violence, and severe physical abuse of children. The central finding is that the average annual cost of interpersonal violence is far larger than that of interstate and civil war, somewhere between five and 20 times larger, with a best estimate of about eight times.Prevalence, not intensity. The reason interpersonal violence costs more in aggregate is that it is far more widespread. Very few countries experience large-scale collective violence in any given year, but almost all countries carry annual death and injury rates from homicide, intimate partner violence, and child abuse that exceed global average war death and injury rates. For 2000 to 2019, the authors estimate a global annual average of not quite 1.5 deaths per 100,000 people from war and terrorism, against about 7 per 100,000 for homicide.Intimate partner violence. The authors estimate global annual averages of about 3,300 and 1,600 per 100,000 people for intimate partner physical and sexual assault respectively, which is roughly twice those rates for women specifically.Severe physical abuse of children. Measured conservatively, capturing beatings far more serious than a mild spanking, the estimates imply that 15% of children aged 14 or younger are subjected to monthly beatings that would be classed as assaults if the victims were adults.Economic costs versus well-being costs. Civil war can cause severe economic devastation in the worst-affected countries, mainly through reduced growth, and at the global level the strictly economic costs of collective violence may exceed those of interpersonal violence. But economic loss is only one cost. Drawing on methods that use what people pay to avoid risks of death or injury, the authors estimate well-being losses that are far greater for interpersonal violence, because it kills and injures so many more people each year. The authors note that the difficulty of estimating the economic cost of interpersonal violence means their figures probably understate it relative to collective violence.Why interpersonal violence stays invisible. National media and political debate focus far more on collective violence, partly because it is dramatic and episodic while interpersonal violence is persistent and, happening inside households, often practically invisible. Sustained public and policy attention on the scale of interpersonal violence is itself a step towards reducing its costs.It is not just "culture". Against the view that little can be done because interpersonal violence is cultural, the authors point to a broad range of programmes and policies with evidence behind them. For homicide and intimate partner violence, measures that reduce alcohol access and consumption. For intimate partner violence and child abuse, adolescent dating programmes and parenting programmes. Across all forms, police reform to improve accountability and training, and more police in countries with low ratios of police to homicides.Reducing collective violence. There is reasonable evidence that UN peacekeeping operations are a relatively inexpensive way to lower violence in civil war countries and to reduce the chance of war resuming after a peace agreement. The authors note that rising conflict among the permanent five members of the UN Security Council, and sharpening regional rivalries among larger states in conflict-affected areas, have sharply reduced the prospects for new peacekeeping operations for now.

Dr. Aaron Zelikovich discusses the frequency of LRP4-IgG in patients with suspected MG using different cell-based assay protocols.  Show citation:  Vacchiano V, Milano DC, Ricciardiello F, et al. Low Prevalence and Inconsistency of LRP4-IgG Detection in Suspected Myasthenia Gravis: A Multicenter CBA Comparison Neurology: Neuroimmunology & Neuroinflammation. 2026;13(3). doi:10.1212/NXI.0000000000200554 

Manisha Shah talks about reducing intimate partner violence among young people in Tanzania. "Sex, Power, and Adolescence: Intimate Partner Violence and Sexual Behaviors" by Manisha Shah, Jennifer Seager, Joao Montalvao, and Markus Goldstein. OTHER RESEARCH WE DISCUSS IN THIS EPISODE: “Income Changes and Intimate Partner Violence: Evidence from Unconditional Cash Transfers in Kenya" by Johannes Haushofer, Charlotte Ringdal, Jeremy P. Shapiro, and Xiao Yu Wang. “The Effect of Cash, Vouchers, and Food Transfers on Intimate Partner Violence: Evidence from a Randomized Experiment in Northern Ecuador” by Melissa Hidrobo, Amber Peterman and Lori Heise. “Love on the Rocks: Domestic Violence and Alcohol Abuse in Rural Mexico” by Manuela Angelucci. “Public Transfers and Domestic Violence: The Roles of Private Information and Spousal Control" by Gustavo J. Bobonis, Melissa González-Brenes, and Roberto Castro. “For Better or For Worse?: Education and the Prevalence of Domestic Violence in Turkey” by Bilge Erten and Pinar Keskin. “Love, hate and murder: Commitment devices in violent relationships” by Anna Aizer and Pedro Dal Bó. “The Gender Wage Gap and Domestic Violence" by Anna Aizer. “Advancing the Agency of Adolescent Girls” by Eric Edmonds, Ben Feigenberg, and Jessica Leight. “Reshaping Adolescents' Gender Attitudes: Evidence from a School-Based Experiment in India" by Diva Dhar, Tarun Jain and Seema Jayachandran. “Effective prevention of intimate partner violence through couples training: a randomised controlled trial of Indashyikirwa in Rwanda" by Kristin Dunkle, Erin Stern, Sangeeta Chatterji, and Lori Heise. “Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial” by Paul M. Pronyk, James R. Hargreaves, Julia C. Kim, Linda A. Morison, Godfrey Phetla, Charlotte Watts, Joanna Busza, and John D.H. Porter. “Transfers, Behavior Change Communication, and Intimate Partner Violence: Postprogram Evidence from Rural Bangladesh" by Shalini Roy, Melissa Hidrobo, John Hoddinott, and Akhter Ahmed. “Theoretical Underpinnings and Meta-analysis of the Effects of Cash Transfers on Intimate Partner Violence in Low-and Middle-Income Countries" by Victoria Baranov, Lisa Cameron, Diana Contreras Suarez and Claire Thibout. "A rigorous global evidence review of interventions to prevent violence against women and girls" by Alice Kerr-Wilson, Andrew Gibbs, Erika McAslan Fraser, Leanne Ramsoomar, Anna Parke, Hussaind M.A. Khuwaja, and Rachel Jewkes. "Guy Talk: Catalyzing Peer Effects on IPV through Virtual Support Groups for Men" by Christopher Boyer, Erica Field, Rachel Lehrer, Andrew Morrison, and Claudia Piras. "Multifaceted Programs Targeting Women In Fragile Settings: Evidence from the Democratic Republic of Congo" by Manuela Angelucci, Rachel Heath, and Eva Noble. "Harm and Harmony" by Siwan Anderson and Chris Bidner. Want more? Check out my new book! The Science of Second Chances: A Revolution in Criminal Justice is available now. I have a Substack! Sign up for Probable Causation: The Newsletter.

Today's episode includes a look at the intersection of housing policy and HMDA data. Plus, Robbie interviews Equifax's Justin Demola on how rising credit costs, higher borrower fallout rates, and inefficient credit-pull strategies are increasing origination expenses, making it critical for lenders to manage credit usage more strategically while leveraging reforms to improve efficiency and reduce costs. And we close with a look at the increasing prevalence of buydowns as a percentage of originations.Thank you to Equifax, a global data, analytics, and technology company, which helps mortgage lenders gain the borrower and market insights they need to improve efficiency and make accurate decisions. Access differentiated consumer credit data, powerful consumer and market insights, and income and employment data from The Work Number.The Chrisman Commentary is your go-to daily mortgage news podcast, where industry insights meet expert analysis. Hosted by Robbie Chrisman, this podcast delivers the latest updates on mortgage rates, capital markets, and the forces shaping the housing finance landscape. Whether you're a seasoned professional or just looking to stay informed, you'll get clear, concise breakdowns of market trends and economic shifts that impact the mortgage world.

Inclusion Matters welcomes Dr. Jenn Hall-Lande, licensed psychologist and researcher from the University of Minnesota Institute on Community Integration and Masonic Institute for the Developing Brain back to the program to share updated autism prevalence numbers in Minnesota.  She helps us understand the trends in the research and gives useful insights on ways early educators can support early intervention efforts and partner with families.

How has AI changed cybersecurity and enterprise networks? In this interview, Michael (General Manager for Cisco's Campus Networking) joins David Bombal to discuss the real-world impact of agentic AI, physical AI, and modern security threats. Discover why the U.S. cybersecurity agency (CISA) reports that the mean time to exploit vulnerabilities has plummeted from 10 months to just 10 hours due to AI systems chaining CVEs together. Learn how autonomous agents are shifting campus and branch environments from traditional north-south traffic to massive east-west flows, creating up to 9x the bandwidth demand. Michael breaks down how network segmentation and "least agency" protect data, how Cisco Live Protect utilizes eBPF inside the Linux kernel to create a compensating shield before a patch is ready, and how line-rate encryption with post-quantum cryptography protects against "harvest now, decrypt later" threats. Finally, find out why network engineering remains an incredibly critical, high-demand career path in 2026. Big thanks to ‪@Cisco‬ for sponsoring my trip to Cisco Live Vegas 2026 // Michael Dickman SOCIAL // LinkedIn: / midickman // David's SOCIAL // Discord: discord.com/invite/usKSyzb Twitter: www.twitter.com/davidbombal Instagram: www.instagram.com/davidbombal LinkedIn: www.linkedin.com/in/davidbombal Facebook: www.facebook.com/davidbombal.co TikTok: tiktok.com/@davidbombal YouTube: / @davidbombal Spotify: open.spotify.com/show/3f6k6gE... SoundCloud: / davidbombal Apple Podcast: podcasts.apple.com/us/podcast... // MY STUFF // https://www.amazon.com/shop/davidbombal // SPONSORS // Interested in sponsoring my videos? Reach out to my team here: sponsors@davidbombal.com // MENU // 0:00 - Coming Up 0:28 - Intro 0:53 - Concerns about Agentic AI 03:55 - Agent's Impact on the Network 05:25 - Agents and Cybersecurity 07:05 - Prevalence of Agentic AI 08:04 - Solving Cybersecurity in Your Enterprise 11:29 - Agentic AI and Firewalls 13:43 - Cisco's Live Protect 17:00 - Cisco and Quantum 19:13 - Cisco Cloud Control 20:45 - Still Networking as a Career? 21:35 - Outro Please note that links listed may be affiliate links and provide me with a small percentage/kickback should you use them to purchase any of the items listed or recommended. Thank you for supporting me and this channel! Disclaimer: This video is for educational purposes only. #cisco #agenticai #networking

In this podcast, Mariya Saify discusses her paper 'Prevalence of autism in children with epilepsy: A population-based study'.   The paper is available here: https://doi.org/10.1111/dmcn.70288   Follow DMCN on Podbean for more:  https://dmcn.podbean.com/ ___ Watch DMCN Podcasts on YouTube: https://bit.ly/2ONCYiC __ DMCN Journal: Developmental Medicine & Child Neurology (DMCN) has defined the field of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families.   DMCN Journal - https://onlinelibrary.wiley.com/journal/14698749 ___ Find us on Twitter! @mackeithpress - https://twitter.com/mackeithpress

Next week, Matt Knaggs and Colin Goodman will attempt to set a Guinness World Record for running the 350-mile length of Ireland with MS. This week, you'll meet Matt and Colin and learn why this undertaking is so important to each of them.  We're also sharing survey results that point to gaps in how we approach MS care from the day of diagnosis. We'll tell you what it really means when you read that the prevalence of MS is increasing. It isn't bad news at all! We'll provide you with all the details you need to register for ECTRIMS Patient Community Day. And, if you can spare 20 minutes, we'll tell you how you can participate in an MS research study from the comfort of your own home. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: We're hitting the open road in Ireland with Matt Knaggs and Colin Goodman  :22 Survey points to gaps in how we approach MS care from day one  2:48 What does the increase in MS prevalence really mean?  8:48 Register for ECTRIMS 2026 Patient Community Day  12:33 An opportunity for you to participate in MS research without leaving home   14:10 Matt Knaggs and Colin Goodman talk about their attempt to set a Guinness World Record for running the length of Ireland with MS  15:56 Share this episode  32:13 Next week  32:33 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/460 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com STUDY: Understanding the Unmet Needs of People with MS at Diagnosis and Throughout Their Care Journey: Insights from a Survey-Based Study https://link.springer.com/article/10.1007/s40120-026-00942-y STUDY: Drivers of Prevalence in Major Motor Neurodegenerative Diseases: Temporal Trends in Sweden and France (2003-2022) https://www.neurology.org/doi/10.1212/WNL.0000000000218072 REGISTER: ECTRIMS 2026 Patient Community Day https://www.ectrimspatientcommunity.eu PARTICPATE IN RESEARCH: Survey: Automatic and Reflective Determinants, Fatigue, and Physical Activity for People with Multiple Sclerosis https://purdue.ca1.qualtrics.com/jfe/form/SV_douenJftXAcGxVk JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 460 Guest: Matt Knaggs, Colin Goodman Privacy Policy

SIBO & Parasite Antimicrobial Protocol: https://drruscio.com/biofilm-protocol/?nab=0&utm_source=youtube  Elemental Diet: https://store.drruscio.com/pages/elementalheal  Triple Therapy Probiotics: https://store.drruscio.com/products/triple-therapy-probiotic  Gut Rebuild Nutrients: https://store.drruscio.com/products/gut-rebuild-nutrients-powder-chocolate?srsltid=AfmBOopnMhnrTlDklAWPUIyuoOFwM3FwTahLXX4888KzfgBc-Ym9bUvt    Parasites are an often-overlooked factor in chronic gut symptoms, food intolerance, histamine-type reactions, fatigue, and cases where patients feel stuck despite addressing SIBO, Candida, or other common gut imbalances. In this episode, Dr. Ruscio, Dr. Jake Vonfeldt, and Dr. Scott Spiridigliozzi discuss common parasites like Giardia, Cryptosporidium, Blastocystis, pinworms, and helminths, why standard testing can miss them, and how clinical history can help determine when parasites deserve closer consideration. They also share both natural and pharmaceutical parasite protocols, along with practical guidance on when each approach may be appropriate.   ✅Start healing with us! Learn more about our virtual clinic:  https://drruscio.com/virtual-clinic/

► Build stable, secure relationships without the push and pull: https://understandable.net (ad)Welcome to today's episode! In this video I explain how to tell if someone has narcissim or an avoidant attachment style.► Links and Resources:Can Patients With Narcissistic Personality Disorder Change? Paper: https://pubmed.ncbi.nlm.nih.gov/38949659/ Narcissistic Personality Disorder: Progress in Understanding and Treatment: https://psychiatryonline.org/doi/full/10.1176/appi.focus.20220052 Earned Secure Attachment Paper: https://journals.sagepub.com/doi/abs/10.1177/00332941241277495 Prevalence of Narcissism Paper: https://pubmed.ncbi.nlm.nih.gov/20579503/ The first 10,000 Adult Attachment Interviews Paper: https://pubmed.ncbi.nlm.nih.gov/19455453/ Deactivation Video: https://youtu.be/fi-wUf36e9k?si=MsjjB-DCVic0sUPY 8 Phases How I Healed Avoidant Attachment Patterns Video: https://www.youtube.com/watch?v=4SrSolyrSCQ ► Subscribe On Your Favorite Platform! YouTube: ⁠https://www.youtube.com/channel/UCGiJdF0yeTyRJanW_uSICDw?sub_confirmation=1⁠ Spotify: ⁠https://open.spotify.com/show/2gaheQLxBwByM9txVzlpI6 Apple Podcasts: ⁠https://podcasts.apple.com/gb/podcast/understandable/id1399616905 Amazon Music: ⁠https://music.amazon.de/podcasts/ee3580cb-61c5-4aa1-9ad4-1204014078e7/understandable⁠ ► Episode Timestamps:00:00 Intro01:49 How Many People are Avoidant vs. Narcissistic?03:41 Narcissism vs. Avoidant Attachment Behaviors21:43 The Overlap: Similarities26:18 Can They Change and become available for Relationships?29:30 How To Change: What Actually Matters► Reach Out To Me :)E-Mail: info@understandable.net► Hi, my name is Robert! I make videos about how to build stable, secure relationships without losing yourself or waiting forever for the “perfect” partner. :)► Disclaimer: None of the contents are therapeutic or medical recommendations. The contents are not to be understood as therapeutic-medical instructions and are neither intended as professional health advice nor as education.I am not a health professional myself. My content is based on research and my personal experiences working with various therapists as a client for three years.

On Episode 65 of the Stroke Alert Podcast, host Dr. Negar Asdaghi highlights two articles from the June 2026 issue of Stroke: "AI-Derived LA Volume Index, LA/RA and LA/LV Volume Ratios From Coronary Artery Calcium Scans Predict Long-Term Atrial Fibrillation and Stroke" and "Prevalence and Association of Atherosclerosis to Ischemic Stroke in Patients With Atrial Fibrillation on Anticoagulation." She also interviews Dr. Randolph Marshall, principal investigator of the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis–Hemodynamics (CREST-H) study. For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260603.690307

Dr. Maarten Cruyff is an Assistant Professor in the Faculty of Social and Behavioural Sciences and Chair of Methodology and Statistics at Utrecht University. In this episode, he discusses how methods used to measure doping prevalence have changed over time, his work on different models for collecting and analyzing responses from athlete surveys about doping, his role in the World Anti-Doping Agency's Prevalence Working Group, current challenges that remain in determining doping prevalence, and more.

Could you have metabolic dysfunction even at a normal weight?This episode challenges everything we've been taught about weight and health. Dr. Cooper reveals that up to 25% of normal-weight people have metabolic syndrome, yet they're rarely screened because doctors assume they're healthy based on appearance alone.KEY TAKEAWAYSWeight and metabolic health are not the same thing - you can be metabolically unhealthy at any sizeNormal weight people with metabolic dysfunction are often overlooked and undertreated by healthcare providersKey screening tests include fasting glucose, insulin, HbA1c, triglycerides, HDL cholesterol, blood pressure, and inflammatory markers like HSCRPMetabolic dysfunction can start in your 20s and take decades to develop into serious diseaseBoth normal weight and higher weight patients face bias - normal weight people aren't screened enough, while higher weight people have everything blamed on their weightEarly screening and treatment can prevent catastrophic health outcomes later in lifeThe liver plays a crucial role in metabolism and can become insulin resistant regardless of body weightNOTABLE QUOTE"You cannot tell anything about someone's health from their outside, what they look like or what, even what they're doing necessarily, but definitely not their body size. So you can be healthy or unhealthy at any size body, and I think that's what's overlooked quite a bit." — Dr. Emily CooperLinks & ResourcesPodcast Home: fatsciencepodcast.comCooper Center for Metabolism: coopermetabolic.comResources from Dr. Cooper: coopermetabolic.com/resourcesJoin Our Community: patreon.com/cw/FatSciencePodcastSubmit Your Question: questions@fatsciencepodcast.com or dr.c@fatsciencepodcast.comAppendix: Key ReferencesPrimary literature supporting this episode•       Wang et al. Prevalence of Metabolically Unhealthy Normal Weight and Its Influence on the Risk of Diabetes. Journal of Clinical Endocrinology & Metabolism, 2023.•       Review: Beyond BMI — Rethinking Obesity Metrics and Cardiovascular Risk in the Era of Precision Medicine. Journal of Clinical Medicine, December 2025.•       Korean meta-analyses on metabolic dysfunction phenotypes and cardiometabolic risk, Cardiovascular and Metabolic Sciences Journal review, 2024.•       Frontiers in Nutrition, January 2026. Associations of metabolic heterogeneity with the progression of cardiometabolic multimorbidity.•       International Journal of Obesity, September 2025. Cardiovascular risk factors associated with metabolic health phenotypes.Mechanism references•       MASLD — metabolic dysfunction-associated steatotic liver disease — nomenclature and clinical framework. AASLD/EASL consensus, 2023.•       Insulin signaling, adipose tissue dysfunction, and ectopic fat deposition — reviews on the upstream-downstream relationship.•       Epicardial adipose tissue and cardiovascular dysfunction — Frontiers in Cardiovascular Medicine, January 2026.Fat Science is supported by the Diabesity Institute, a nonprofit dedicated to increasing access to effective, science-based metabolic care.This podcast is for informational purposes only and is not intended as medical advice. Please consult with a qualified healthcare provider for personalized recommendations.

If you've ever had urinary symptoms that antibiotics didn't fix — and your cultures kept coming back negative — this episode is for you.A new 2026 study in the Journal of Sexual Medicine followed 253 women with recurrent UTIs and persistent urogenital symptoms despite negative urine cultures. What researchers found reframes everything: 85% of these women had hormonally mediated vestibulodynia, 75% had pelvic floor hypertonicity, and only 15% had a classic urologic cause for their symptoms.This isn't a bladder problem. It's a hormone problem — and the vulvar vestibule, urethra, and bladder are one integrated, estrogen- and androgen-responsive system. Whether it presents as genitourinary syndrome of menopause (GSM) in a postmenopausal woman or hormonally mediated vestibulodynia in a younger one, the tissue-level pathophysiology is the same.In this episode, Dr. Carolyn Moyers breaks down:• Why persistent urinary symptoms after negative cultures have a hormonal explanation• The shared embryologic origin of the vestibule, urethra, and bladder trigone — and why it matters• How androgen deficiency drives vestibular inflammation, pelvic floor guarding, and bladder dysfunction in a self-perpetuating cycle• Why this affects premenopausal women too — 98.9% of premenopausal patients in the study had below-range free testosterone• What the Rubin et al. 2025 data adds: vaginal prasterone (DHEA) was associated with meaningfully lower UTI rates in women with vulvovaginal atrophy — treating the hormone environment changed the urological outcome• What integrated treatment looks like — vaginal estrogen for GSM, compounded estradiol/testosterone gel for vestibulodynia, pelvic floor PT for hypertonic muscles• The honest limits of this research: selection bias, non-uniform hormonal evaluation, absence of long-term outcome data — and what prospective studies still need to answerThis episode builds directly on Episode 149 — When Sex Hurts with Dr. Jill Krapf. If you haven't listened to that one, it is linked below and is essential companion listening.https://podcasts.apple.com/us/podcast/sky-womens-health/id1541657642?i=1000630939731

Adverse drug events cause 5-15% of admissions to hospital and drug-drug interactions make up about a fifth of these. Most common are pharmacodynamic situations where two drugs have a similar outcome thereby overdoing the intended outcome. Pharmacokinetic interactions are more complicated to understand as they're more indirect. For example, while medications are cleared by oxidative metabolism in the liver and gut, there are many drugs that interfere with the function of the cytochrome enzymes responsible. This can result in clearance of the first drug at too fast or too slow a rate.Polypharmacy has become more frequent over the decades with more than half of people over the age of 75 on five or more prescriptions. This episode examines some of the systems that have led to current rates of polypharmacy, and strategies for deprescribing safely in a given patient. We're REWINDing it nine years after it was first published to celebrate the career of Professor Ric Day who has just retired after sixty years of service at St Vincent's Hospital, Sydney. He has been a much-appreciated clinician and prolific research academic with several hundred published papers that have been cited more than forty thousand times.Chapters0:50 Prevalence of drug interactions5:52 Pharmacodynamic vs pharmacokinetic interactions 9:25 Cytochrome enzymes17:33 ACE inhibitors and more26:48 Strategies for deprescribingGuests Professor Richard Day AM MBBS, FRACP (St Vincent's Hospital; UNSW),Professor Sarah Hilmer AM PhD FRACP FAAHMS (Royal North Shore Hospital; Kolling Institute/ USyd). ProductionProduced by Mic Cavazzini DPhil. Music courtesy of FreeMusicArchive includes ‘Flying Pea' and ‘Cherry Blossom' by Daddy Scrabble and “Manly Nunn Steps Out” by Doctor Turtle. Music licenced from Epidemic Sound includes ‘Train Ride' (Instrumental) by Alex Kehm and ‘Yellow Leaf' by Autohacker. Image adapted for RACPAdd educational activity to MyCPD as educational activity or visit web page for a transcript and references.Key ReferencesLife-threatening drug interactions: what the physician needs to know [Internal Medicine Journal] Polypharmacy in older people: when should you deprescribe? [Medicine Today]

In this episode with Mitchell Selhorst, we discuss a recent paper in which he was lead author looking at standard care of spondylolysis. We explore:  ·       What is spondylolysis?·       Prevalence of spondylolysis·       Standard care of spondylolysis·       Evidence based care of spondylolysis e.g. “Immediate functional progression program”·       Role of education in this population

Content warning: childhood abuse, childhood sexual abuse, sexual assault, rape, abduction, missing persons, gun violence, murder, and mental illness.Amber Rodgers is a survivor, business professional, and creative from Texas. As early as she can remember, her life was filled with chaos. By the time she was fourteen, she was a multi-crime survivor, and by 19 she would serve as a witness in her best friend's murder trial. Amber moved forward by cultivating a successful career and loving family, until her past trauma instigated a cascading effect in her mental health and relationships. Although Amber has shared portions of her story at-large, it took her decades and a life-altering mental health journey to realize the deep impact her teen years had had on her. The Broken Cycle Media team is deeply appreciative of Amber's transparency, rawness, and advocacy. These episodes are dedicated in loving memory of Kytrina Marie Locascio.Sources: -Centers for Disease Control and Prevention. “About Adverse Childhood Experiences.” CDC, U.S. Department of Health and Human Services, 2025, https://www.cdc.gov/violenceprevention/aces/. -Centers for Disease Control and Prevention. “Adverse Childhood Experiences (ACEs).” CDC Vital Signs, U.S. Department of Health and Human Services, https://www.cdc.gov/vitalsigns/aces/index.html. -Centers for Disease Control and Prevention. “Psychosocial Factors and Health Equity.” CDC, U.S. Department of Health and Human Services, https://www.cdc.gov/dhdsp/health_equity/psychosocial.htm. -Felitti, Vincent J., et al. “Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults: The Adverse Childhood Experiences (ACE) Study.” American Journal of Preventive Medicine, vol. 14, no. 4, 1998, pp. 245–258.-Hughes, Karen, et al. “The Effect of Multiple Adverse Childhood Experiences on Health: A Systematic Review and Meta-Analysis.” The Lancet Public Health, vol. 2, no. 8, 2017, pp. e356–e366. doi:10.1016/S2468-2667(17)30118-4.-McKay, Matthew T., Laura Kilmartin, Aisling Meagher, Mary Cannon, Colm Healy, and Mary C. Clarke. “A Revised and Extended Systematic Review and Meta-Analysis of the Relationship between Childhood Adversity and Adult Psychiatric Disorder.” Journal of Psychiatric Research, vol. 156, 2022, pp. 159–174. PubMed, https://pubmed.ncbi.nlm.nih.gov/36274532/. -Swedo, Elizabeth A., et al. “Prevalence of Adverse Childhood Experiences Among U.S. Adults—Behavioral Risk Factor Surveillance System, 2011–2020.” Morbidity and Mortality Weekly Report, vol. 72, no. 26, 2023, pp. 707–715, https://www.cdc.gov/mmwr/volumes/72/wr/mm7226a2.htm. -Zhang, Y., et al. “Cumulative Adverse Childhood Experiences and Risk of Mental Disorders: A Systematic Review and Meta-Analysis.” Acta Psychiatrica Scandinavica, 2026, https://www.sciencedirect.com/science/article/pii/S0001691826007559. Accessed 2 June 2026.For additional resources and a list of non-profit organizations that can help, please visit http://www.somethingwaswrong.com/resources*Thank you again to Rula and Quince for sponsoring this episode. *Remember, Rula patients typically pay $15 per session when using insurance. Connect with quality therapists and mental health experts who specialize in you at https://www.rula.com/wcn #rulapod *And don't forget to elevate your summer wardrobe, go to quince.com/wcn for free shipping on your order and 365-day returns, now available in Canada too.

Depression is often treated as a single condition. But two people with the same diagnosis can have completely different underlying causes. On this episode of The Dr. Hyman Show, I'm rejoined by Dr. James Greenblatt to explore why depression may be less of a disease and more of a signal that something deeper is going on. We discuss how a root-cause approach can uncover what's driving symptoms and why finding what's beneath them matters. Watch the full conversation on YouTube or listen wherever you get your podcasts. We discuss: Could nutrient deficiencies, inflammation, or gut issues be contributing to symptoms of depression What tests can help uncover the biological factors that may be affecting mood and mental health Why can two people with depression have different root causes—and require different solutions How do blood sugar imbalances, hormone changes, and metabolic health influence the brain What should you know about antidepressants, tapering, and addressing the factors that may affect recovery Hope doesn't come from ignoring symptoms—it comes from understanding them. Sometimes the most important question isn't "What's wrong with me?" but "What might my body be trying to tell me?" One of the key themes in this conversation is that mental health is deeply connected to what's happening throughout the body. In my Brainshaping Academy, you'll learn how to support the biological systems that shape cognitive, emotional, and mental well-being. View Show Notes From This Episode Depression symptoms aren't always just “in your head.” Dr. Hyman's Brainshaping Academy shows how your gut, immune system, and nutrient levels may be responsible—and what you can do about it. → https://drhyman.com/products/brainshaping?utm_source=dr_hyman_show&utm_medium=newsletter&utm_campaign=may_27&utm_content=link Get Free Weekly Health Tips from Dr. Hyman https://drhyman.com/pages/picks?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Sign Up for Dr. Hyman's Weekly Longevity Journal https://drhyman.com/pages/longevity?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Join the 10-Day Detox to Reset Your Health https://drhyman.com/pages/10-day-detox Join the Hyman Hive for Expert Support and Real Results https://drhyman.com/pages/hyman-hive This episode is brought to you by Seed, Made In Cookware, Perfect Amino, BON CHARGE, and Big Bold Health.Go to seed.com/hyman and use code 20HYMAN to get 20% off your first month.Visit madeincookware.com and use code HYMAN10 for 10% off your order.Go to bodyhealth.com and use code HYMAN20 to get 20% off your first order.Head to boncharge.com/hyman and use code HYMAN for 15% off.Go to bigboldhealth.com/drhyman and use code HYMAN15 to save 15% on your first order. (0:00) Antidepressants, Cooking at Home, and Introducing the Brain Shaping Academy (3:14) Prevalence of Depression and Personal Stories (4:27) Exploring Root Causes of Depression (5:07) Influential Figures and Orthomolecular Psychiatry (12:29) Gut Health, Gluten Sensitivity, and Brain Inflammation (20:22) Neuroinflammation and Root Causes of Depression (22:10) Biomarkers, Hormonal Imbalances, and Insulin Resistance (25:34) The Role of Toxins and Diagnostic Testing (31:15) Case Studies and Patient Stories (34:29) Challenges in the Mental Health System (37:05) Effectiveness of Antidepressants and Patient Resistance (43:17) Role and Need for Nutritional Lithium (45:00) Sponsor: Big Bold Health (46:00) Identifying Nutritional Lithium Need (47:13) Integrating Modalities and Supplements vs. Medications (48:04) Psychotherapy Methods and Addressing Root Causes (49:34) Dr. Greenblatt's Book and the Finding a Living Platform (51:03) Systematic Approach and Global Impact of Depression (52:39) Sharing, Disclaimer, and Closing Remarks

This episode of the Mind the Kids podcast features Dr. Joanne Park, clinical psychologist and Principal Investigator of the Parenting Resilient Kids (Park) Lab at Mount Royal University, Canada. Hosted by Clara Faria, the conversation explores emerging research on “climate worry” in early adolescence, drawing on Dr. Park's recent publication in Child and Adolescent Mental Health.Dr. Park examines whether concerns about climate change represent a distinct psychological construct or are simply an extension of generalised anxiety. The discussion unpacks the difference between affective climate worry—emotional responses to climate change—and cognitive climate worry, which reflects more developed fears about future impact. Importantly, the findings suggest that climate worry is not only common among younger adolescents but may also have unique associations with wellbeing, independent of general anxiety.The episode also highlights key developmental, social, and gender-related factors shaping how young people experience climate-related distress. Dr. Park discusses why girls and gender-diverse adolescents may report higher levels of climate worry, and considers how clinicians, educators, and parents can respond without over-pathologising what may be a rational reaction to the climate crisis.This conversation is essential listening for clinicians, researchers, and educators interested in child and adolescent mental health, particularly those working with anxiety, emotional development, and the psychological impact of global challenges. It also offers practical insight into how to support young people in managing climate-related concerns through adaptive coping and resilience-building strategies.Read the CAMH journal paper ‘Prevalence, conceptual distinctiveness, and cross-sectional correlates of climate worry in Canadian adolescents' - https://doi.org/10.1111/camh.70076Joanne L. Park, Audrey-Ann Deneault, Brae Anne McArthur, Suzanne Tough, Sheri MadiganFirst published: 18 February 2026Get a free CPD/CME certificate for listening to this podcast by registering for a FREE ACAMH Learn account at https://bit.ly/4fF4BBWVisit https://www.acamh.orgFacebook and LinkedIn search / ACAMHInstagram https://www.instagram.com/assoc.camhBluesky https://bsky.app/profile/acamh.bsky.socialX https://x.com/acamh

The Point returns for another season to dive deep into topics capturing the nations interest, bringing Aboriginal and Torres Strait Islander perspective to the forefront. This weeks episode of The Point asks "Why racism back in fashion?".

fWotD Episode 3310: Physella acuta Welcome to featured Wiki of the Day, your daily dose of knowledge from Wikipedia's finest articles.The featured article for Thursday, 28 May 2026, is Physella acuta.Physella acuta, also known as the European physa, tadpole snail, sewage snail, bladder snail, or acute bladder snail, is a species of small, air-breathing freshwater snail of the family Physidae. It originates from North America and was first described in 1805 by Jacques Philippe Raymond Draparnaud based on a specimen found in France. Like other physids, P. acuta presents a sinistral (left-coiling) shell as well as a unique set of muscles called the physid musculature that allows it to rapidly twist the shell as a defence mechanism.P. acuta is invasive on all continents except Antarctica and is considered by Dillon and colleagues (2002) as "the world's most cosmopolitan freshwater gastropod". Its first introduction outside North America likely occurred through the 18th-century cotton trade to Europe, while later spread mainly happened through the aquarium trade. The species can occupy diverse freshwater habitats and tolerates polluted as well as oxygen-poor environments. It can reproduce with other individuals and also self-fertilise. Due to its high reproductive rate and tolerance to habitat degradation, it frequently outcompetes native snail species. Prevalence of parasitic infections within invasive P. acuta populations is often low, but a 2024 study detected the human parasite Echinostoma (which causes a disease known as echinostomiasis upon infecting the gastrointestinal tract) in an individual from Rio de Janeiro, Brazil. In aquariums, P. acuta is usually introduced through ornamental plants and can become a "nuisance snail" due to its rapid reproduction. However, a controlled population in an aquarium can help clean up organic leftovers and control algal growth.This recording reflects the Wikipedia text as of 00:15 UTC on Thursday, 28 May 2026.For the full current version of the article, see Physella acuta on Wikipedia.This podcast uses content from Wikipedia under the Creative Commons Attribution-ShareAlike License.Visit our archives at wikioftheday.com and subscribe to stay updated on new episodes.Follow us on Bluesky at @wikioftheday.com.Also check out Curmudgeon's Corner, a current events podcast.Until next time, I'm standard Joanna.

Helen Brough joins the Saranya to reflect on her work in paediatric food allergy, from personal experiences that shaped her career to landmark studies like LEAP, EAT, and ProNuts that transformed prevention and management. This episode explores early allergen introduction, evolving approaches to treatment, and what's driving the rise in food allergies in children.  Timestamps:   00:53 –  Raising children with atopy  02:18 – Antibiotic exposure at birth  03:08 – Prevention of peanut allergies   05:22 – Introducing other allergens 08:09 – Multi-nut/sesame allergy  10:41 – Immunotherapy for severe allergies  13:36 – Prevalence of food allergies 

Dr Funmi Okunola MD interviews Dr Guillaume Dedet MD, MPH, MSc, MA - Senior Health Economist at the Organisation for Economic Co-Operation and Development (OECD) andDr David Kelly MD, MPH, MRCIP, CSCST - Public Health Physician & Epidemiologist at the OECD about their April 2026 report - "Addressing the Costs & Care of Long COVID for Long COVID the Long Shadow of the Pandemic". We also dive into their October 2025 OECD report - "The Prevalence and Impact of Long COVID in the Primary Care Population - Findings from the OECD PaRIS Survey".REFERENCES 1. Addressing the Costs & Care of Long COVID for Long COVID the Long Shadow of the Pandemic. 2. The Prevalence and Impact of Long COVID in the Primary Care Population - Findings from the OECD PaRIS Survey

Lipoprotein(a) or Lp(a) is suddenly all the rage because several drug companies are working on medications to lower this previously resistant form of cholesterol. Almost entirely genetic, unaffected by diet or lifestyle, it has numerous studies linking it to heart disease and aortic valve calcification. But it may not be the ticking time bomb some influencers like to claim.   Become a supporter of our show today either on Patreon or through PayPal! Thank you! http://www.patreon.com/thebodyofevidence/ https://www.paypal.com/donate?hosted_button_id=9QZET78JZWCZE   Email us your questions at thebodyofevidence@gmail.com.   Editor:    Robyn Flynn Theme music: “Fall of the Ocean Queen“ by Joseph Hackl Rod of Asclepius designed by Kamil J. Przybos Chris' book, Does Coffee Cause Cancer?: https://ecwpress.com/products/does-coffee-cause-cancer   Obviously, Chris is not your doctor (probably). This podcast is not medical advice for you; it is what we call information. References: The genetic nature of Lp(a) levels: https://pubmed.ncbi.nlm.nih.gov/1386087/ Prevalence of elevated Lp(a) in 500,000 US patients https://pubmed.ncbi.nlm.nih.gov/27659098/ Prevalence of elevated Lp(a) in 2.9 million Chinese adults https://pubmed.ncbi.nlm.nih.gov/40266173/ Prevalence of elevated Lp(a) in the INTERASPIRE study https://pubmed.ncbi.nlm.nih.gov/40436467/ Variation of Lp(a) by sex: https://pubmed.ncbi.nlm.nih.gov/27659098/ One of the many studies linking Lp(a) to cardiovascular disease https://pubmed.ncbi.nlm.nih.gov/33115266/ High Lp(a) and aortic stenosis: https://www.nejm.org/doi/full/10.1056/NEJMoa1109034 FH and Lp(a) https://pubmed.ncbi.nlm.nih.gov/32466883/ The ongoing Lp(a) trials https://familyheart.org/lpa-clinical-trials  

Gen Alpha has completely fragmented away from traditional TV, leaving advertisers scrambling to connect with kids and parents across YouTube, FAST channels, and gaming platforms.  This week, Mike sits down with Emma Witkowski, VP of Media Solutions at WildBrain, to unpack the massive market disconnect in children's media, the power of nostalgia in family co-viewing, and how upcoming privacy regulations like COPPA 2.0 are rewriting the rules of digital targeting. Key Highlights:

Is hypercortisolism the hidden culprit in a significant proportion of both difficult-to-treat diabetes and resistant hypertension? In part 4 of our special series, Dr. Neil Skolnik speaks with John Buse, MD to explore the effects of hypercortisolism, until just recently considered a vanishingly rare condition. This special episode is sponsored with support from Corcept. Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts, Amazon Music, Spotify, or your preferred podcast platform. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John Buse, MD, The Verne S. Caviness Distinguished Professor and director of the Diabetes Center at the University of North Carolina at Chapel Hill School of Medicine, a past president of medicine & science at the American Diabetes Association (ADA), and recipient of the ADA Outstanding Achievement in Clinical Diabetes Research Award Selected references: Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes. Diabetes Care April 2025 Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment. Diabetes Care June 2025 MOMENTUM: Hypercortisolism Present in 1-in-4 with Resistant Hypertension. HCP Live March 2026

PodChatLive 230: Reconceptulising the calf muscles, and osteoarthritis prevalence in professional footballersContact us: getinvolved@podchatlive.comLinks from this episode:Synergistic yet different: Rethinking the gastrocnemii as two functionally distinct musclesPrevalence of foot/ankle osteoarthritis and pain in retired male professional footballers compared to general population male controls

In this episode of the Open Bedroom Podcast, I sit down with Jeff Abraham, CEO of Prometheus, a sexual wellness brand. Jeff shares how Prometheus developed their patented delay sprays and wipes to help men with premature ejaculation by reducing hypersensitivity—without numbing their partners. We dive into the "orgasm gap" between men and women, the importance of foreplay and communication, and why normalizing masturbation for men matters. Jeff also talks about female arousal gels, cock rings, and their Go Solo lotion. Throughout the episode, we focus on removing shame around sexual wellness and encourage couples to explore intimacy openly using the right tools.Unrealistic Expectations from Porn (00:00:01)Discusses how porn creates anxiety and unrealistic expectations about sex and performance.Origins of Promescent and PE Treatments (00:01:51)Jeff explains the founding of Promescent, early PE treatments, and the science behind their delay spray.How the Delay Spray Works (00:04:05)Details on the lidocaine-based spray, its unique formulation, and how it avoids numbing partners.The Orgasm Gap and Coping Mechanisms (00:06:14)Discusses the average duration of intercourse for men and women, the orgasm gap, and coping strategies.PE's Prevalence and Misdiagnosis (00:08:42)PE is more common than ED; misdiagnosis and psychological impacts are discussed.Anxiety, Confidence, and Sexual Performance (00:09:57)Explores the link between anxiety, confidence, and sexual performance in men.Impact of Porn on Sexual Expectations (00:13:38)How porn distorts expectations and increases anxiety for both men and women.Communication and Learning Your Partner (00:22:24)Importance of communication, understanding partner preferences, and overcoming shame in sexual relationships.Sex Education and Breaking Stereotypes (00:29:53)Lack of proper sex education, breaking myths about orgasms, and understanding female anatomy.Stigma and Physiology of Premature Ejaculation (00:56:48)Addressing stigma, physiological causes of PE, and the need for open discussion and solutions.Shop Promescent:https://www.promescent.com/Follow The Open Bedroom Podcast:https://www.instagram.com/theopenbedroompodcast/

AC joint injuries can quietly sabotage your performance, from dancers lifting arms overhead, actors performing stage combat, to singers holding props or standing for extended periods. In this episode of Performers Happiness in the Arts (PHARTS), Jenna Kantor, PT, DPT, dance medicine specialist and performer, explains how to identify, treat, and prevent AC joint injuries. Topics covered include: Prevalence in performers: 8–12% of dancers, 10–15% of actors, and 7–10% of singers (Micheli et al., Boston, 2016; Fryer, Australia, 2018; Ackermann et al., Sydney, 2017) Traumatic vs. overuse injuries Physical therapy strategies: manual therapy, scapular and rotator cuff strengthening, mobility restoration, and stage-specific return-to-dance training Prevention tips to maintain healthy, expressive arm lines

Welcome to Hacking Your ADHD. I'm your host, William Curb, and I have ADHD. On this podcast, I dig into the tools, tactics, and best practices to help you work with your ADHD brain. Today, I'm joined by Skye Waterson for our research recap series. In this series, we take a look at a single research paper, dive into what the paper says, how it was conducted, and try and find any practical takeaways. In this episode, we're going to be discussing a paper called "Prevalence, Patterns, and Predictors of Sleep Problems and Daytime Sleepiness in Young Adolescents with ADHD." And so this is a study that's investigating the high prevalence of sleep-related issues in adolescents with ADHD, and this paper is also trying to distinguish between, like, nighttime sleepiness disorders and daytime sleepiness. So the story here being that, hey, maybe ADHD might not be caused by poor sleep quality alone, but there are, like, strong links to other things like sluggish cognitive tempo, which we'll all get into. So how about that? Let's dive in. If you'd life to follow along on the show notes page you can find that at https://HackingYourADHD.com/293 https://tinyurl.com/56rvt9fr - Unconventional Organisation Affiliate link https://tinyurl.com/y835cnrk - YouTube https://www.patreon.com/HackingYourADHD - Patreon

Join Sue for an upcoming Live Virtual Workshop where you will learn from Sue practical tips & strategies to make a difference. In this episode, we will discuss: ✅ AuDHD: Autism and ADHD diagnosed together in same person. ✅ RSD: 98% with ADHD experience hypersensitivity to negative feedback. ✅ Prevalence: 50-70% of autistic people also have ADHD. ✅ Contradictions: AuDHD students need routine some days, variety others. ✅ Sensory: Often overlooked in ADHD but highly impactful. ✅ Strategies: Use visuals, kinesthetic learning, movement breaks consistently. ✅ Management: Label emotions and take thoughts to court. Read more about this podcast in the show notes found via the link below suelarkey.com.au/audhd-classroom-support-strategies Join the Facebook group specifically for this podcast www.facebook.com/groups/suelarkeypodcastcommunity/ Join my Neurodiversity Network suelarkey.com.au/neurodiversity-network/ Follow my Instagram account for regular tips www.instagram.com/sue.larkey/ To learn more about teaching or understanding ASD, please visit my website below. elearning.suelarkey.com.au

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this Mind Moments episode, Greg Pontone, MD, Chief of Aging Behavioral and Cognitive Neurology at the University of Florida, joins the podcast to discuss the interplay between cognition and Parkinson disease, with a focus on how clinicians can better recognize and manage cognitive changes across the disease course. Pontone outlines the prevalence of early cognitive impairment, noting that a significant proportion of patients may present with subtle deficits at diagnosis, particularly in executive function and processing speed. The conversation explores the impact of commonly used medications on cognition, including anticholinergics and benzodiazepines, and how clinicians can balance therapeutic benefit with cognitive risk. Pontone also reviews current treatment strategies, including cholinesterase inhibitors and memantine, while emphasizing the importance of nonpharmacologic approaches such as structured routines and cognitive training. Additional discussion highlights the evolving role of biomarkers, the overlap between Parkinson disease and Alzheimer pathology, and the need for earlier recognition, better patient education, and continued research to improve long-term cognitive outcomes in this population.Looking for more Movement disorder discussion? Check out the NeurologyLive® Movement disorder clinical focus page.Episode Breakdown: 1:10 – Prevalence and early signs of cognitive impairment in Parkinson disease  2:30 – Medication-related cognitive effects and contributing drug classes 4:20 – Balancing therapeutic benefit vs cognitive risk in treatment decisions 6:05 – Current treatments for cognition, including pharmacologic and behavioral strategies 10:25 – Neurology News Network  13:00 – Role of biomarkers and Alzheimer overlap in Parkinson cognition 15:45 – Future priorities for advancing cognitive care and research in PD The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Clears Cala kIQ Plus for Essential Tremor and Parkinson Disease Hand Tremor FDA Issues Complete Response Letter for GTx-104 in Patients With Aneurysmal Subarachnoid Hemorrhage Satralizumab Meets Primary End Point in Phase 3 METEOROID Study in MOGAD Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

In this episode of One in Ten, host Teresa Huizar speaks with researcher Dr. Elizabeth Jeglic about preventing educator sexual misconduct, which has increased in schools even as abuse rates have declined in other youth-serving settings. Dr. Jeglic describes limited prior research since a 2004 Department of Education report and presents her team's survey of 6,600 recent high school graduates: 11.7% reported some form of educator sexual misconduct and about 1% reported contact abuse, with survivors reporting grooming as a near-universal pathway.  Time Stamps:  Time. Topic 00:00 Why Schools Are Riskier 01:44 Research Gap and New Data 03:13 What Counts as Misconduct 03:49 Grooming and Boundary Creep 08:32 Mentorship Versus Betrayal 09:58 High Risk Roles and Spaces 12:33 Prevalence and What It Means 14:03 Building a Culture of Safety 16:58 Training That Names Educators 19:03 Codes of Conduct That Work 19:37 No Touching Policies 20:57 Online Contact Boundaries 23:04 Pass the Trash Fixes 24:09 Supervision and Student Reporting 26:02 Progress and Patchwork Rules 27:25 Policy Reforms and Grooming Laws 30:29 Mandated Reporting Gaps 32:33 Why Data Stays Spotty 35:14 Parents Prevention Playbook 37:24 Research Updates and Wrap UpResourcesNational Blueprint | National Center to S.E.S.A.M.E.Support the showDid you like this episode? Please leave us a review on Apple Podcasts.

Alpha-gal syndrome is an emerging and often underrecognized allergy triggered by a tick bite that can cause delayed reactions to red meat and mammalian-derived products. In this episode, host Stacy Lauderdale is joined by clinical experts Zack Stacy and Kyna Henrici to unpack the science behind alpha-gal, its implications in healthcare settings, and the operational challenges providers face in managing this complex condition.    Guest Speakers:   Zachary Stacy, Pharm.D., MS, FCCP, BCPS  Clinical Pharmacy Specialist, Surgery  BJC Health   Kyna Henrici, RN  Medical Evidence Director - Cardiovascular  Vizient, Inc.    Host:    Stacy Lauderdale, Pharm.D., BCPS  AVP, Evidence-Based Medicine  Vizient, Inc.    00:05 – Introduction  Podcast introduction and welcome to VerifiedRx  00:14 – What is alpha-gal syndrome  Overview of alpha-gal syndrome  Delayed allergic reactions after eating red meat  Often linked to tick bites  00:48 – Meet the Guests   Zack Stacy, clinical pharmacy specialist  Kyna Henrici, medical evidence director  01:10 – Understanding the Allergy  Alpha-gal is a carbohydrate in nonprimate mammals that can trigger an allergy in humans  Key difference is delayed reaction timing  Symptoms are not always easy to trace   01:32 – How It Develops  Triggered by tick bites  Immune system produces IgE antibodies   Oral exposure to alpha-gal leads to delayed reactions  IV exposure to alpha-gal can cause immediate reactions  02:17 – Prevalence and Diagnosis Challenges  More common in Midwest and southern United States  Likely underdiagnosed  Often mistaken for general food allergies  Allergy may fade over time  03:07 – Risks in Healthcare Settings  Patient safety concerns beyond food  Mammalian components in medications and devices  Examples include heparin and surgical materials  03:44 – Hidden Medication Risks  Inactive ingredients can be animal derived  Examples include glycerin, lactose, amino acids, stearates  Difficult to identify and track  04:42 – Lack of Transparency  No centralized ingredient database  Sourcing can change frequently  Variability across manufacturers and batches  05:33 – Screening in Surgical Settings  Medication review at NDC level  Identification of active and inactive ingredients  May require contacting manufacturers  06:45 – Timing Challenges  Urgent procedures limit investigation time  Manufacturer responses may take days  Alternative medications often needed  07:14 – Identifying At Risk Patients  Many patients are unaware they have alpha-gal syndrome  Screening includes questions about dairy tolerance  Three patient categories used for evaluation  08:32 – Using Dairy as a Screening Tool   Dairy tolerance helps guide risk level  Food exposure typically higher than medication exposure  Determines need for deeper review  09:12 – Managing Emergencies  Focus shifts from avoidance to risk mitigation  Use of team communication and clear documentation  Preparation for unavoidable exposure  10:03 – Prevention and Preparedness  Stock alpha-gal safe medications when possible  Prepare for allergic reactions with standard treatments  10:47 – Team Based Care Approach  Collaboration across care teams is essential  Premedication strategies may be used  Close monitoring for reactions  11:11 – Gaps in Care  Limited visibility into product ingredients  Need for better labeling and transparency  11:33 – Need for Standardization  Call for clearer guidance and clinician education  Desire for centralized resource for medication ingredients  12:24 – Monitoring Challenges  CDC tracking decreased after privatization of testing  Cases likely still increasing  12:53 – Closing Remarks    Links and Resources: Alpha-gal Syndrome | Alpha-gal Syndrome | CDC    Subscribe Today!  Apple Podcasts  Spotify  YouTube  RSS Feed   

In this Supplement Ingredient Series episode, Nurse Doza breaks down glutathione — the master antioxidant your liver makes to fight inflammation, detox your body, and protect your brain. With roughly 1 in 4 people worldwide carrying a fatty liver, most are running on low reserves. Learn why glutathione is non-negotiable for energy, performance, and recovery — plus how to get your own vial to use at home. Featured Partner: SHED SHED delivers practitioner-grade glutathione in a vial you can use at home — the same master antioxidant Nurse Doza has administered through thousands of injections and IVs in clinical practice. Because the liver's ability to produce glutathione drops when it's fatty, inflamed, or overworked, supplementing directly is often the fastest way to restore energy, mental clarity, and detoxification pathways — exactly the mechanism discussed in this episode.

What is behind the rise in autism diagnoses? Join Jeremy Veenstra-VanderWeele, MD, professor of developmental neuropsychiatry at Columbia University, and JAMA Psychiatry Editor Dost Öngür, MD, PhD, as they discuss the history of autism spectrum disorder, the role that genetics and environmental factors play, the importance of early intervention in treatment, and more with JAMA Senior Editor Derek Angus, MD, MPH. Related Content: Autism—Understanding Diagnosis, Prevalence, and Treatment

What if the biggest threat to your dental practice isn't competition… but your own physical health? In this eye-opening episode, Dr. Len Tau sits down with Caitlin Parsons, dental hygienist and ergonomics and wellness consultant, to unpack how chronic pain and stress are silently impacting productivity, team dynamics, and patient experience. Caitlin shares her personal journey from nearly leaving dentistry due to pain to becoming a leader in helping dental professionals create sustainable, high-performing practices. From small ergonomic tweaks to integrating yoga therapy into your daily workflow, this conversation reveals how prioritizing wellness isn't just good for your body… it's a smart business move. If you've ever pushed through discomfort or felt burnout creeping in, this episode is your wake-up call to rethink how you care for yourself and your team.   What You'll Learn Why chronic pain is so common in dentistry and what causes it The connection between stress, posture, and patient experience How poor ergonomics impacts productivity and team performance Simple ergonomic adjustments that can make a big difference Why "pushing through pain" can cost you long-term The role of yoga therapy in managing stress and improving focus Practical ways to support your team's health without major investments How small daily habits can improve longevity in your career — Key Takeaways 00:49 Introduction & Episode Overview 02:55 Caitlin Parsons' Background & Journey 05:55 Prevalence of Pain in Dentistry 07:05 Signs of Poor Ergonomics 09:20 Impact of Stress & Chronic Pain on Performance 12:00 Real-Life Story on Patient Perception 14:36 Desk Ergonomics & Daily Habits 16:41 What is Ergonomic Optimization? 19:04 Small Changes That Make a Big Impact 20:55 The Danger of Ignoring Pain 23:40 Introduction to Yoga Therapy 26:55 Actionable Steps for Practice Owners 31:00 Lightning Round Q&A 34:40 How to Connect with Caitlin — Connect with Caitlin Website: thealignedhygienist.com Email: hello@thealignedhygienist.com Instagram: @thealignedhygienist

Great communication isn't about saying more—it's about making what you say matter.If we want to communicate more effectively, we need to treat communication less like a habit—and more like a series of intentional choices. In this special feed drop, we're featuring a conversation from the ⁠Masters of Scale⁠ podcast, where host ⁠Jeff Berman⁠ sits down with Stanford lecturer and ⁠Think Fast, Talk Smart ⁠host Matt Abrahams to explore what it really takes to communicate with intention.Most of us default to what feels natural—long-winded openings, generic pitches, or focusing on what we want to say. But as Matt explains, effective communication starts with the audience. Get to the point quickly. Focus on what's relevant. “Tell the time, don't build the clock.”From high-stakes presentations to job interviews and everyday interactions, Matt shares practical, science-backed strategies for showing up with clarity and confidence. Communication is something we all do every day—but doing it well, especially when it counts, takes intention. As this conversation makes clear, small shifts in how we prepare, structure, and deliver our message can make all the difference.Episode Reference Links:Jeff BermanMasters of ScaleConnect:Premium Signup >>>> Think Fast Talk Smart PremiumEmail Questions & Feedback >>> hello@fastersmarter.ioEpisode Transcripts >>> Think Fast Talk Smart WebsiteNewsletter Signup + English Language Learning >>> FasterSmarter.ioThink Fast Talk Smart >>> LinkedIn, Instagram, YouTubeMatt Abrahams >>> LinkedInChapters:(00:00) - Introduction (04:02) - Communication as a Skill (04:32) - The Impact of Communication (05:10) - Prevalence of Speaking Anxiety (07:11) - Techniques for Reducing Anxiety (09:46) - Core Principles: Repetition, Reflection, Feedback (10:53) - Communication in Education (12:03) - Opportunities to Improve Communication (14:26) - Presenting & Pitching Ideas (16:41) - Setting Clear Expectations (19:58) - Characteristics of Productive Meetings (24:13) - The Role of Repetition in Leadership (25:03) - Structured Preparation for Interviews (26:29) - The ADD Framework for Responses (27:57) - Asking Insightful Questions (29:17) - Defining Communication Objectives (32:23) - Adapting Messages to Different Formats (33:38) - Building Confidence in New Mediums (34:48) - Recovering from Cognitive Lapses (36:14) - The Pace, Space, Grace Framework (38:09) - Navigating Differing Perspectives (40:01) - Conclusion ********Thank you to our sponsors.  These partnerships support the ongoing production of the podcast, allowing us to bring it to you at no cost.Strawberry.me. Get 50% off your first coaching session today at Strawberry.me/smartJoin our Think Fast Talk Smart Learning Community and become the communicator you want to be. 

In this essential conversation, Dr. Linda Bluestein welcomes pelvic health physical therapist and dance science expert Dr. Brooke Winder to explore the often-hidden intersection of pelvic health, performance, and joint hypermobility. Dr. Winder shares her professional insights and personal history with urinary leakage as a young athlete, shedding light on why over a third of professional dancers and aerialists experience similar symptoms. The discussion unpacks the "hypermobility paradox", where muscles become chronically overactive to compensate for lax ligaments, and how this tension can lead to pelvic pain, incontinence, and sexual dysfunction. From the impact of under-fueling (REDs) to the surprising connection between jaw tension and the pelvic floor, this episode provides a roadmap for athletes and non-athletes alike to "zoom out" and find holistic strategies for recovery and resilience. Takeaways: The Hypermobility Paradox: People with lax connective tissue often have hyperactive pelvic floor muscles that work overtime to provide the stability their ligaments cannot. Prevalence in Performance: Around 34% of professional dancers and 40% of aerialists report urinary leakage, even those who have never been pregnant or given birth. The "Zoom Out" Method: Pelvic health is influenced by the entire body; issues in the jaw (TMJ), neck, and hips can directly contribute to pelvic floor tension and pain. REDs and Incontinence: Low energy availability (under-fueling) can weaken skeletal muscles, including the pelvic floor, and is now recognized as a health consequence of Relative Energy Deficiency in Sport. Autonomic Influence: The pelvic floor is highly responsive to the nervous system; conditions like POTS can trigger bladder urgency and disrupt coordination. Agency in Therapy: Pelvic floor PT does not always require an internal exam; many improvements can be made through external assessment, virtual coaching, and movement strategies Find the episode transcript here. Want more Dr. Brooke Winder? https://www.instagram.com/drbrookewinderpt/ Go to cozyearth.com and use my Promo Code: BENDYBOGO Go to AirDoctorPro.com and use promo code BENDY_ to get UP TO $300 off today! Want more Dr. Linda Bluestein, MD? Website: https://www.hypermobilitymd.com/ YouTube: https://www.youtube.com/@bendybodiespodcast Instagram: ⁠⁠⁠⁠https://www.instagram.com/hypermobilitymd/⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠https://www.facebook.com/BendyBodiesPodcast⁠⁠⁠⁠ X: ⁠⁠⁠⁠https://twitter.com/BluesteinLinda⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠https://www.linkedin.com/in/hypermobilitymd/⁠⁠⁠⁠ Newsletter: ⁠⁠⁠⁠https://hypermobilitymd.substack.com/ Shop my Amazon store ⁠⁠⁠ https://www.amazon.com/shop/hypermobilitymd Dr. Bluestein's Recommended Herbs, Supplements and Care Necessities: https://us.fullscript.com/welcome/hypermobilitymd/store-start For Appointments and Questions: RUVAEDSCenter@uvahealth.org UVA EDS: https://www.uvahealth.com/healthy-practice/advancing-care-through-ehlers-danlos-clinic UVA EDS FAQ: https://www.uvahealth.com/support/eds/faq UVA Pediatric Integrative Medicine: https://childrens.uvahealth.com/specialties/integrative-health Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them. Join YOUR Bendy Bodies community at ⁠⁠https://www.bendybodiespodcast.com/⁠⁠. YOUR bendy body is our highest priority!⁠⁠ Learn more about Human Content at ⁠⁠⁠http://www.human-content.com⁠⁠⁠ Podcast Advertising/Business Inquiries: ⁠⁠⁠sales@human-content.com⁠⁠⁠ Part of the Human Content Podcast Network FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links Learn more about your ad choices. Visit megaphone.fm/adchoices

"Giving up smoking is the easiest thing in the world. I know because I've done it thousands of times". - Mark Twain While not an episode about nicotene withdrawal, this week we're talking all about research describing the phenomenon of relapse. Or is it renewal? Resurgence? All of the above? Basically any situation in which behavior, once thought removed from a repertoire, comes screaming back into reality. Regardless, teaching skills without planning for generalization to different contexts or being unsure when extinction will come into play is a recipe for disaster. Fortunately, some great researchers have been in the behvaior analysis kitchen trying to cook up the perfect meal of learning. This episode is available for 1.0 LEARNING CEU. Articles discussed this episode: Shahan, T.A. (2020). Relapse: An introduction. Journal of the Experimental Analysis of Behavior, 113, 8-14. doi: 10.1002/jeab.578 Mitteer, D.R., Greer, B.D., Fisher, W.W., Briggs, A.D., & Wacker, D.P. (2018). A laboratory model for evaluating relapse of undesirable caregiver behavior. Journal of the Experimental Analysis of Behavior, 110, 252-266. doi: 10.1002/jeab.462 Podlesnik, C.A., Ritchey, C.M., Muething, C., & Falligant, J.M. (2025). Different criteria affect prevalence of relapse of behavior targeted for treatment. Journal of Applied Behavior Analysis, 58, 225-231. doi: 10.1002/jaba.2927 Muething, C., Call, N., Ritchey, C.M., Pavlov, A., Bernstein, A.M., & Podlesnik, C.A. (2022). Prevalence of relapse of automatically maintained behavior resulting from context changes. Journal of Applied Behavior Analysis, 55, 138-153. doi: 10.1002/jaba.887 If you're interested in ordering CEs for listening to this episode, click here to go to the store page. You'll need to enter your name, BCBA #, the two episode secret code words, and answers to the knowledge check questions to complete the purchase. Email us at abainsidetrack@gmail.com for further assistance.

We’re excited today to launch our first episode in collaboration with the Irish Thoracic Society and their podcast series. The Irish Thoracic Society represents respiratory professionals throughout Ireland and is dedicated to championing excellence in the prevention, diagnosis, and clinical care of respiratory disease through its work in advocacy, education and research. In today’s episode, we explore the complex and often overlooked world of refractory chronic cough — a condition that can significantly impact patients' quality of life but is frequently misunderstood or underdiagnosed. With insights from leading respiratory specialists in Ireland and the United States, we discuss the latest thinking on diagnosis, management, and emerging treatments aimed at improving outcomes for patients and helping clinicians navigate this challenging area of respiratory medicine. Joining us are renowned experts Professor Lorcan McGarvey and Professor Brendan Canning, both internationally recognised leaders in respiratory medicine and cough research. Together, they share their perspectives on the neurobiology of chronic cough, the considerable morbidity experienced by patients, and how clinicians can approach diagnostic investigations more effectively. We also explore current treatment strategies and promising new therapies on the horizon as chronic cough increasingly gains recognition as a disease in its own right — rather than simply a symptom. Whether you’re a clinician, researcher, or simply interested in advances in respiratory medicine, this episode offers valuable insights into a condition that is finally receiving the attention it deserves. Meet Our Co-Hosts Marissa O'Callaghan is an Irish trained Respiratory fellow currently undertaking a post-doc fellow working in Erasmus MC Rotterdam in the Netherlands. She finished her Irish respiratory and Internal medicine training and Phd in 2025. Her areas of interest are interstitial and rare lung diseases. She enjoys clinical research, Med Ed, and dreaming up new medical innovations. Together with cohost Sandra Green, she founded the ITS podcast series in June 2024. Marissa O’Callaghan –LinkedIn Sandra Green is an Irish-trained respiratory fellow with a strong track record in climate advocacy and multidisciplinary sustainable initiatives, as co-founder of Irish Doctors for the Environment. She has an MSc in Leadership and Innovation in Healthcare at the Royal College of Surgeons Ireland (2023–2025). With Marisssa, she co-founded the Irish Thoracic Society Podcast Productions, launching the platform in 2024 to share knowledge, insights, and innovations in respiratory care. Sandra Green – LinkedIn Meet Our Guests Lorcan McGarvey is a professor of respiratory medicine at the University of Belfast, with a focus on the neurobiology of cough. His research has significantly contributed to the understanding of cough hypersensitivity syndrome and the development of new therapeutic strategies. Lorcan is a respected voice in the field, known for his collaborative work and dedication to advancing respiratory health. Brendan Canning is a distinguished researcher at Johns Hopkins University, specializing in the mechanisms of cough and airway diseases. His pioneering studies on neural pathways and receptor targets have paved the way for novel treatments in refractory chronic cough. Brendan’s expertise and innovative approach make him a key figure in the ongoing efforts to redefine chronic cough management. In This Episode The definitions and classifications of chronic cough, including unexplained, refractory, and unexplained refractory cough The importance of a thorough clinical history and focused diagnostics over exhaustive testing Common causes of chronic cough The role of personalized, multidisciplinary management—combining pharmacologic, speech therapy, and psychological support—to improve quality of life for even the most challenging patients. The concept of cough hypersensitivity syndrome and its role in refractory cases Evidence-based approach to treatment, including pharmacologic and non-pharmacologic options Emerging therapies on the horizon, including novel receptor modulators and neuromodulatory agents and ongoing clinical trials in this rapidly evolving field The impact of chronic cough on mental health, social life, and overall quality of life The importance of reframing chronic cough as a disease entity in its own right References and Further Reading Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet. 2008;371(9621):1364-1374. Gibson PG, Vertigan AE. Management of chronic refractory cough. BMJ. 2015;351:h5590. Matsumoto H, Kanemitsu Y, Ohe M, Tanaka H, Terada K, Nishi K, et al. Real-world usage and response to gefapixant in refractory chronic cough. ERJ Open Res. 2025;11(4):01037-2024. doi:10.1183/23120541.01037-2024. McGarvey LP, Birring SS. Cough hypersensitivity syndrome: a novel paradigm for understanding cough. Lancet Respir Med. 2014;2(8):647-656. Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Ribas CD, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1):1901136. Parker SM, Smith JA, Birring SS, Chamberlain-Mitchell S, Gruffydd-Jones K, Haines J, et al. British Thoracic Society clinical statement on chronic cough in adults. Thorax. 2023;78(Suppl 1):S3-S19. Smith JA, Woodcock A. Chronic cough. N Engl J Med. 2006;354(2):136-144. Song WJ, Dupont L, Birring SS, Chung KF, Dąbrowska M, Dicpinigaitis P, et al. Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study. ERJ Open Res. 2023;9(6):00618-2023. doi:10.1183/23120541.00618-2023. Song WJ, McGarvey L, Cho PSP, Mazzone SB, Chung KF, editors. Chronic cough. Sheffield: European Respiratory Society; 2025.

April showers are fun, especially after winter snowstorms. Fortunately, we've thawed out a whole mess of episodes for you to enjoy this month including our latest grab bag. But what about the themed episodes? Glad you asked! First, we'll be talking all about relapse which includes discussions of resurgence and renewal (see, aren't you glad you're learning about this?). Then we're joined by Armando Bernal to discuss how PECS could be a key component of building up our support of assent practices. Finally we get real and talk about peer mediation. The kind where children support skill acquisition of their with cues and praise. Not the other one. That'll get its own episode someday. All that and a new LISTENER POLL! Articles for April 2026 Golden Grab Bag (Spring Grab Bag 2026) Loomis, K. Morales, L., Yeo, Y., & Fienup, D.M. (2026). Turning the page: Increasing young children's preference for looking at and engaging with books. Journal of Applied Behavior Analysis, 59. doi: 10.1002/jaba.70051 Bigwood, L., Staples, E., & Sharp, R. (2026). Making preference assessments more acceptable and effective for people with dementia. Behavior Analysis in Practice. doi: 10.1007/s40617-025-01145-x Kaplan, B. A., Gelino, B. W., & Reed, D. D. (2018). A behavioral economic approach to green consumerism: Demand for reusable shopping bags. Behavior and Social Issues, 27, 20-30. doi: 10.5210/bsi.v.27i0.8003   Relapse Shahan, T.A. (2020). Relapse: An introduction. Journal of the Experimental Analysis of Behavior, 113, 8-14. doi: 10.1002/jeab.578 Mitteer, D.R., Greer, B.D., Fisher, W.W., Briggs, A.D., & Wacker, D.P. (2018). A laboratory model for evaluating relapse of undesirable caregiver behavior. Journal of the Experimental Analysis of Behavior, 110, 252-266. doi: 10.1002/jeab.462 Podlesnik, C.A., Ritchey, C.M., Muething, C., & Falligant, J.M. (2025). Different criteria affect prevalence of relapse of behavior targeted for treatment. Journal of Applied Behavior Analysis, 58, 225-231. doi: 10.1002/jaba.2927 Muething, C., Call, N., Ritchey, C.M., Pavlov, A., Bernstein, A.M., & Podlesnik, C.A. (2022). Prevalence of relapse of automatically maintained behavior resulting from context changes. Journal of Applied Behavior Analysis, 55, 138-153. doi: 10.1002/jaba.887   Assent and PECS w/ Armando Bernal Allen, L.L., Mellons, L.S., Syed, N., Johnson, J.F., & Bernal, A.J. (2024). Neurodiversity-affirming applied behavior analysis. Behavior Analysis in Practice. doi: 10.1007/s40617-024-00918-0 Doherty, A., Bracken, M., & Gormley, L. (2018). Teaching children with autism to initiate and respond to peer mands using picture exchange communication system (PECS). Behavior Analysis in Practice, 11, 279-288. doi: 10.1007/s40617-018-00311-8   Peer Mediation Morrison, L., Kamps, D., Garcia, J., & Parker, D. (2001). Peer mediation and monitoring strategies to improve initiations and social skills for students with autism. Journal of Positive Behavior Interventions, 3, 237-250. doi: 10.1177/10983007010030040 Beaulieu, L., Hanley, J.P., & Roberson, A.A. (2013). Effects of peer mediation on preschoolers' compliance and compliance precursors. Journal of Applied Behavior Analysis, 46, 555-567. doi: 10.1002/jaba.66 Grauvogel-MacAleese, A.N. & Wallace, M.D. (2010). Use of peer-mediated intervention in children with attention deficit hyperactivity disorder. Journal of Applied Behavior Analysis, 43, 547-551. doi: 10.1901/jaba.2010.43-547

This month: Multiple FDA regulatory decisions germane to dermatology, psoriasis and lupus; and Eosinophilic Fasciitis (EF) reminder and should you worry about fibromyalgia? Show Notes: 1. FDA Approves Icotrokinra for Plaque Psoriasis The FDA approved an oral IL-23 inhibitor, icotrokinra (Icotyde), for use in moderate-to-severe plaque psoriasis in adults and children 12 years of age and older who are candidates for systemic therapy or phototherapy, according to a https://t.co/q5b3TceFHx 2. FDA has approved secukinumab (Cosentyx) for use pediatric patients (aged 12yrs) with moderate to severe hidradenitis suppurativa  https://t.co/oX4LGU16QP 3. FDA has accepted the supplemental biologics license application for use of interleukin-23 inhibitor tildrakizumab (Ilumya; Sun Pharma) in active psoriatic arthritis (PsA) in adults. https://t.co/cwqz9DoWsL https://t.co/ut0A4MwqW7 4. TYK2 Inhibitor Deucravacitinib FDA Approved for Psoriatic Arthritis On Friday, March 6th, the FDA approved deucravacitinib (Sotyktu) for the treatment of adults with active PsA based on the results of the pivotal Phase 3 POETYK PsA-1 and POETYK PsA-2 clinical trials. https://t.co/a6rmortnoS 5.vUCB announced topline results of the BE-BOLD head-to-head study where bimekizumab (IL-17i) was superior to risankizumab (IL-23i) study; 553 active PsA in achieving an ACR50 response at 16 weeks. Enrolled PsA pts were either bilogic naïve or who had previous exposure to 1 TNFi 6. Retrospective TriNetX Network cohort study of adult PsA (N 123,031) pts, propensity- matched to non-PsA controls. PsA had signif higher CV morbidity: MACE (HR 1.74); mortality (HR 1.95); CHF (HR 1.96), MI (HR 1.71), & CVA (HR 1.49). bDMARDs reduced MACE (HR 0.95) & mortality (HR 0.92) vs csDMARDs   https://t.co/bHrq9KpwBM 7. Prevalence of fibromyalgia in PsA = 18%. FM-PsA pts have higher scores Dz activity scores from FM, rather than inflammation. Fibromyalgia is assoc w/ worse disease outcomes, including failure to achieve low disease activity state and poorer response to therapy. https://t.co/utQRXPmpDs 8. JAMA Patient Education Page on JAMA Eosinophilic Fasciitis (EF). EF is rare, but begins with swelling and redness of the arms and/or legs. Later the skin thickens and develops the peau d' orange appearance. EF does not involve fingers or toes, & doesnt have Raynauds https://t.co/WEFFITtmQC 9. REVEAL, a 5-yr real-world study of 236 SLE pts initiating anifrolumab (basekbube SLEDAI-2K 7 for mucocutaneous (67%) & MSK (49%) dz. At 6 months, 26% achieved remission, 66% reached LLDAS, and 57% achieved LLDAS5. Authors claim rapid onset of action https://t.co/16OQatOcPj https://t.co/mU9aciCNcH 10. Update on FDA complete response letter to AZ regarding BLA hold for anifrolumab (Saphnelo) for SC use in SLE. CRL originally issued 10/10/25, but announced 2/3/26. FDA CRL cites critical data quality w/ key analyses in SC-TULIP study. A BLA decision expected in 1st half of 2026 https://t.co/zuwtsdL6I9 11. NEJM: Obinutuzumab in Active Systemic Lupus Erythematosus https://rheumnow.com/news/nejm-obinutuzumab-active-systemic-lupus-erythematosus